⌘K

Home/Filings/4/0001493152-16-010274

4//SEC Filing

Akers Biosciences Inc 4

Accession 0001493152-16-010274

$QCLSCIK 0001321834operating

View on SEC.gov Company Profile

Filed

May 23, 8:00 PM ET

Accepted

May 24, 5:57 PM ET

Size

10.2 KB

Accession

0001493152-16-010274

Insider Transaction Report

Form 4

Period: 2016-05-24

Akers Biosciences IncAKER

Gormally John J

Chief Executive Officer

Transactions

Purchase
Common Stock
2016-05-24$2.19/sh+69$151→ 69 total
Purchase
Common Stock
2016-05-24$2.20/sh+1,000$2,200→ 1,069 total
Purchase
Common Stock
2016-05-24$2.23/sh+100$223→ 1,169 total
Purchase
Common Stock
2016-05-24$2.25/sh+1,131$2,545→ 2,300 total
Purchase
Common Stock
2016-05-24$2.24/sh+200$448→ 2,500 total

Documents

1 file

4
form4.xmlPrimary

Issuer

Akers Biosciences Inc

CIK 0001321834

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001321834

Filing Metadata

Form type: 4
Filed: May 23, 8:00 PM ET
Accepted: May 24, 5:57 PM ET
Size: 10.2 KB

View on SEC.gov